[Form 4] My Size, Inc. Insider Trading Activity

Rhea-AI Filing Summary

My Size, Inc. (MYSZ) reported insider share purchases by its Chief Executive Officer and director, Ronen Luzon. On 11/24/2025, he purchased 235 shares of common stock in an open-market transaction at a weighted average price of $0.885 per share, with individual trade prices ranging from $0.88 to $0.89.

On 11/25/2025, he purchased an additional 14,000 shares of common stock at a weighted average price of $0.895 per share, with trade prices ranging from $0.83 to $0.96. Following these transactions, Luzon directly beneficially owns 71,735 shares of My Size common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Luzon Ronen

(Last) (First) (Middle)

C/O MY SIZE INC.

HANEGEV 4, POB 1026

(Street)

AIRPORT CITY L3 7019900

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
My Size, Inc. [ MYSZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/24/2025		P		235	A	$0.885(1)	57,735	D
Common Stock	11/25/2025		P		14,000	A	$0.895(2)	71,735	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.88 to $0.89 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

2. The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.83 to $0.96 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

	/s/ Ronen Luzon	11/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did My Size (MYSZ) disclose in this Form 4 filing?

The filing shows that Ronen Luzon, Chief Executive Officer and director of My Size, Inc. (MYSZ), purchased additional shares of the company’s common stock in open-market transactions on 11/24/2025 and 11/25/2025.

How many My Size (MYSZ) shares did CEO Ronen Luzon buy?

On 11/24/2025, Ronen Luzon bought 235 shares of My Size common stock, and on 11/25/2025 he bought an additional 14,000 shares, all reported as open-market purchases.

At what prices were the My Size (MYSZ) insider purchases made?

The 11/24/2025 purchase had a weighted average price of $0.885 per share, with trades between $0.88 and $0.89. The 11/25/2025 purchase had a weighted average price of $0.895 per share, with trades between $0.83 and $0.96.

How many My Size (MYSZ) shares does Ronen Luzon own after these transactions?

After the reported transactions, Ronen Luzon directly beneficially owns 71,735 shares of My Size common stock.

What is Ronen Luzon’s role and relationship to My Size (MYSZ)?

Ronen Luzon is listed as both a Director and an Officer of My Size, Inc., serving as the company’s Chief Executive Officer.

Were these My Size (MYSZ) trades part of a Rule 10b5-1 trading plan?

The form includes a checkbox for indicating transactions made under a Rule 10b5-1(c) trading plan, but the excerpt does not show that box as checked for these specific trades.